Transdermal patches drug delivery system are a method of delivering drugs directly through the skin into the bloodstream.It mainly has polymer matrix, drug, penetration accelerator and adhesive layer.Patches can provide controlled, continuous administration of drugs that are easy to eat with minimal side effects and non-invasive.Compared to injectable and oral systems, it avoids first-pass metabolism and is easy to maintain drug concentration, ensuring that drugs reach the body with minimal side effects, ensuring good adhesion and effective release through the skin in the form of skin circulation for hours or days.
This report contains market size and forecasts of Transdermal Patch Drug Delivery System in Global, including the following market information:
Global Transdermal Patch Drug Delivery System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Transdermal Patch Drug Delivery System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Shunt Way Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transdermal Patch Drug Delivery System include Hisamitsu Pharmaceutical, Novartis, ProSolus, Tapemark, Tesa Labtec, NITTO DENKO CORPORATION, Noven Pharmaceuticals, LTS Lohmann Therapie-Systeme and Medherant, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transdermal Patch Drug Delivery System companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal Patch Drug Delivery System Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Transdermal Patch Drug Delivery System Market Segment Percentages, by Type, 2021 (%)
Shunt Way
Intercellular Lipid Structure Pathway
Trans-cellular Pathway
Global Transdermal Patch Drug Delivery System Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Transdermal Patch Drug Delivery System Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Home Care
Other
Global Transdermal Patch Drug Delivery System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Transdermal Patch Drug Delivery System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal Patch Drug Delivery System revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Transdermal Patch Drug Delivery System revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu Pharmaceutical
Novartis
ProSolus
Tapemark
Tesa Labtec
NITTO DENKO CORPORATION
Noven Pharmaceuticals
LTS Lohmann Therapie-Systeme
Medherant
Corium
Antares Pharma
Syntropharma
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical